enVVeno Medical Corporation Common Stock (NVNO) Stock Price

NVNOStock

$7.47−72.67%52W

Market Cap$5.19M

P/E—

PEG Ratio—

Div yield—

Beta1.36

NVNO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-42.30%

Price vs S&P 500 (4W)-16.13%

VGM Score24.20

Book Value / Share (Quarterly)$30.71

P/TBV (Annual)1.31x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-21.73

Price vs S&P 500 (YTD)-44.46%

Gross Margin (TTM)100.00%

Net Profit Margin (TTM)-5483.33%

EPS (TTM)$-25.19

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-25.19

EPS (Annual)$-1.29

ROI (Annual)-52.18%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-7032.74%

Cash / Share (Quarterly)$31.93

ROA (Last FY)-48.94%

EBITD / Share (TTM)$-26.47

ROE (5Y Avg)-65.39%

Operating Margin (TTM)-4461.11%

Cash Flow / Share (Annual)$-23.74

P/B Ratio0.25x

P/B Ratio (Quarterly)0.35x

Net Income / Employee (Annual)$-666,700

Net Interest Coverage (TTM)-117.55x

ROA (TTM)-56.83%

EPS Incl Extra (Annual)$-1.29

Current Ratio (Annual)13.58x

Quick Ratio (Quarterly)11.39x

3-Month Avg Trading Volume0.02M

52-Week Price Return-72.67%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$2.63

P/S Ratio (Annual)173.01x

Asset Turnover (Annual)0.01x

52-Week High$28.70

Operating Margin (5Y Avg)-6266.24%

EPS Excl Extra (Annual)$-1.29

CapEx CAGR (5Y)-51.16%

26-Week Price Return-32.40%

Quick Ratio (Annual)13.29x

13-Week Price Return-30.80%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)11.70x

Enterprise Value$2.35M

Asset Turnover (TTM)0.03x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-25433.33%

Cash / Share (Annual)$43.01

3-Month Return Std Dev68.53%

Net Income / Employee (TTM)$-476,500

ROE (Last FY)-52.18%

Net Interest Coverage (Annual)-87.25x

EPS Basic Excl Extra (Annual)$-1.29

Receivables Turnover (TTM)2.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-25.19

Receivables Turnover (Annual)2.00x

ROI (TTM)-62.28%

P/S Ratio (TTM)28.84x

Pretax Margin (5Y Avg)-7056.77%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$4.09

Price vs S&P 500 (52W)-88.20%

Year-to-Date Return-33.48%

5-Day Price Return-8.34%

EPS Normalized (Annual)$-1.29

ROA (5Y Avg)-54.58%

Net Profit Margin (Annual)-25433.33%

Month-to-Date Return-4.23%

Cash Flow / Share (TTM)$-2.12

EBITD / Share (Annual)$-1.40

Operating Margin (Annual)-25600.00%

ROI (5Y Avg)-64.31%

EPS Basic Excl Extra (TTM)$-25.19

P/TBV (Quarterly)2.03x

P/B Ratio (Annual)0.24x

Inventory Turnover (TTM)9.33x

Pretax Margin (TTM)-5483.33%

Book Value / Share (Annual)$41.36

Price vs S&P 500 (13W)-33.49%

Beta1.36x

P/FCF (Annual)57.67x

Revenue / Share (TTM)$0.00

ROE (TTM)-62.28%

52-Week Low$7.01

mGradeD

vgmGradeD

NVNO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 30, 2026	-$4.69	-$5.37	-14.50%(-$0.68)
Q1 2026	May 6, 2026	—	-$5.89	—
Q2 2025	Jul 31, 2025	-$9.80	-$11.55	-17.86%(-$1.75)

NVNO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.17

4.29

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NVNOenVVeno Medical Corporation Common Stock	—	—	D	28.8x	—	100.0%	-4461.1%	$7.47
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About enVVeno Medical Corporation Common Stock

enVVeno Medical Corp develops bioprosthetic venous valve replacements to treat venous disease. The company's lead product, VenoValve, is a surgical replacement currently in a U.S. pivotal trial, while its pipeline includes enVVe, a non-surgical transcatheter option. Both products are designed to restore valve function and improve blood circulation in the legs.

NVNO Insider Transactions

SellSep 11, 2026
DUHAY FRANCIS
Director
Shares: 11Value: $123

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

LUCYInnovative Eyewear, Inc. Common StockOphthalmic Goods
CLGNCollPlant Biotechnologies Ltd Ordinary SharesOrthopedic & Prosthetic Devices
NIKINiki BioSolutions, Inc. Common StockMeasuring & Controlling Devices
MITQMoving iMage Technologies, Inc.Photographic Equipment & Supplies
APMAptorum Group Limited Class A Ordinary SharesMeasuring & Controlling Devices
FCUVFocus Universal Inc. Common StockIndustrial Instruments
POASPhaos Technology Holdings (Cayman) LimitedIndustrial Instruments
NXLNexalin Technology, Inc. Common StockElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$7.01

High$28.70